Fed. Circ. Agrees Purdue's OxyContin Patent Is Obvious
The only claim in a Purdue Pharma LP patent covering a way to make its OxyContin painkiller abuse deterrent doesn't hold up, the Federal Circuit said Thursday, affirming a Patent Trial...To view the full article, register now.
Already a subscriber? Click here to view full article